Ann LaCasce, MD
Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. Fellowship Program in Hematology/Oncology Chair. Institute Physician. Associate Professor of Medicine, Harvard Medical School.
Clinical Expertise
Clinical Interests
- CAR T-cell therapy
- Chronic lymphocytic leukemia
- Lymphoma
- Stem cell/bone marrow transplantation
Diseases Treated
- Leukemia, Chronic Lymphocytic (CLL)
- Lymphoma, Hodgkin
- Lymphoma, Non-Hodgkin
About
Ann LaCasce, MD, MMSc, Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves on the Alliance Lymphoma Committee, the National Cancer Comprehensive Lymphoma Guidelines Panel and the Lymphoma Research Foundation’s Scientific Advisory Committee.
Board Certification:
- Internal Medicine, 1999
- Medical Oncology, 2002
Fellowship:
- Dana-Farber/Partners CancerCare, Hematology & Oncology
Residency:
- Brigham and Women's Hospital, Chief Medical Resident
- Brigham and Women's Hospital, Internal Medicine
Medical School:
- Tufts University School of Medicine
Location
Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA
Get the latest thought leadership on CLL delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2022 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811